HC Wainwright Raises BioNTech (NASDAQ:BNTX) Price Target to $150.00
BioNTech (NASDAQ:BNTX – Free Report) had its target price lifted by HC Wainwright from $113.00 to $150.00 in a report released on Monday morning, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for BioNTech’s Q3 2024 earnings at $0.72 EPS, Q4 2024 earnings at $0.47 EPS, […]
10 Oct 08:05 · The Markets Daily